Literature DB >> 11948794

Ureaplasma urealyticum biovar determination in women attending a family planning clinic in Guiné-Bissau, using polymerase chain reaction of the multiple-banded antigen gene.

D Domingues1, L Távora Tavira, A Duarte, A Sanca, E Prieto, F Exposto.   

Abstract

Although Ureaplasma urealyticum is commonly found in the genital tract of asymptomatic women, it has been suggested that only certain subgroups of this microorganism are disease associated. Vaginal specimens were collected to determine the distribution of U. urealyticum biovars and to estimate their possible association with age, absence of lactobacilli, and tetracycline resistance. Of the 94 women studied, 40 (43%) carried U. urealyticum and were biotyped by polymerase chain reaction (PCR). Twenty-nine (73%) strains presented with parvo biovar, 10 (25%) with T960 biovar, and one (2.5%) with both biovars. Parvo biovar was predominant in all age groups and appears to be more frequent in women 20-25 years of age (41%), whereas T960 was common in women 30-35 years of age (22%). In this study, U. urealyticum was not associated with changes in vaginal flora, although the inverse apparently was true for Mycoplasma hominis. However, T960 biovar was more associated with the loss of lactobacilli than was parvo biovar. The number of T960 biovar strains that presented tetracycline (40%) or multiple (100%) resistance was higher than that of parvo biovar strains (27% and 69%, respectively). Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11948794      PMCID: PMC6808028          DOI: 10.1002/jcla.10023

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  27 in total

1.  Serotype diversity and antigen variation among invasive isolates of Ureaplasma urealyticum from neonates.

Authors:  X Zheng; H L Watson; K B Waites; G H Cassell
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

2.  Phylogenetic analysis of Ureaplasma urealyticum--support for the establishment of a new species, Ureaplasma parvum.

Authors:  F kong; G James; Z Ma; S Gordon; W Bin; G L Gilbert
Journal:  Int J Syst Bacteriol       Date:  1999-10

3.  Variable antigens of Ureaplasma urealyticum containing both serovar-specific and serovar-cross-reactive epitopes.

Authors:  H L Watson; D K Blalock; G H Cassell
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

4.  Epitope mapping of the variable repetitive region with the MB antigen of Ureaplasma urealyticum.

Authors:  X Zheng; K Lau; M Frazier; G H Cassell; H L Watson
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

5.  Association of Ureaplasma urealyticum biovars with clinical outcome for neonates, obstetric patients, and gynecological patients with pelvic inflammatory disease.

Authors:  M Abele-Horn; C Wolff; P Dressel; F Pfaff; A Zimmermann
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

6.  Comparative analysis and serovar-specific identification of multiple-banded antigen genes of Ureaplasma urealyticum biovar 1.

Authors:  F Kong; X Zhu; W Wang; X Zhou; S Gordon; G L Gilbert
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Detection of Ureaplasma urealyticum by PCR and biovar determination by liquid hybridization.

Authors:  K Povlsen; J S Jensen; I Lind
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

8.  Organization of Ureaplasma urealyticum urease gene cluster and expression in a suppressor strain of Escherichia coli.

Authors:  O Neyrolles; S Ferris; N Behbahani; L Montagnier; A Blanchard
Journal:  J Bacteriol       Date:  1996-02       Impact factor: 3.490

9.  Ureaplasma urealyticum biovar specificity and diversity are encoded in multiple-banded antigen gene.

Authors:  L J Teng; X Zheng; J I Glass; H L Watson; J Tsai; G H Cassell
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

10.  Small repeating units within the Ureaplasma urealyticum MB antigen gene encode serovar specificity and are associated with antigen size variation.

Authors:  X Zheng; L J Teng; H L Watson; J I Glass; A Blanchard; G H Cassell
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

View more
  6 in total

1.  Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy.

Authors:  Soromon Kataoka; Takashi Yamada; Kazutoshi Chou; Ryutaro Nishida; Mamoru Morikawa; Mashiho Minami; Hideto Yamada; Noriaki Sakuragi; Hisanori Minakami
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

2.  Molecular Detection of Ureaplasma urealyticum from Prostate Tissues using PCR-RFLP, Tehran, Iran.

Authors:  Gholamreza Irajian; Mehri Sharifi; Shiva Mirkalantari; Reza Mirnejad; Mohammad Reza Jalali Nadoushan; Nafiseh Ghorbanpour
Journal:  Iran J Pathol       Date:  2016

3.  Ureaplasma urealyticum is associated with nongonococcal urethritis among men with fewer lifetime sexual partners: a case-control study.

Authors:  Catherine M Wetmore; Lisa E Manhart; M Sylvan Lowens; Matthew R Golden; Nicole L Jensen; Sabina G Astete; William L H Whittington; Patricia A Totten
Journal:  J Infect Dis       Date:  2011-10-15       Impact factor: 5.226

Review 4.  Mycoplasmas and ureaplasmas as neonatal pathogens.

Authors:  Ken B Waites; Brenda Katz; Robert L Schelonka
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

5.  Efficacy of standard therapies against Ureaplasma species and persistence among men with non-gonococcal urethritis enrolled in a randomised controlled trial.

Authors:  Christine M Khosropour; Lisa E Manhart; Catherine W Gillespie; M Sylvan Lowens; Matthew R Golden; Nicole L Jensen; George E Kenny; Patricia A Totten
Journal:  Sex Transm Infect       Date:  2015-01-23       Impact factor: 3.519

6.  Association between asymptomatic sexually transmitted infections and high-risk human papillomavirus in cervical lesions.

Authors:  Lei Wang; Lizhe Zhu; Han Li; Nan Ma; Huifang Huang; Xiaoling Zhang; Ying Li; Jing Fang
Journal:  J Int Med Res       Date:  2019-09-18       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.